Arcadia Biosciences (NASDAQ:RKDA – Get Free Report) is scheduled to issue its quarterly earnings data after the market closes on Tuesday, November 12th. Analysts expect the company to announce earnings of ($0.77) per share for the quarter. Parties that are interested in participating in the company’s conference call can do so using this link.
Arcadia Biosciences (NASDAQ:RKDA – Get Free Report) last announced its earnings results on Tuesday, August 13th. The basic materials company reported $0.78 earnings per share (EPS) for the quarter, missing the consensus estimate of $1.27 by ($0.49). The company had revenue of $1.31 million for the quarter, compared to the consensus estimate of $0.95 million. Arcadia Biosciences had a negative net margin of 127.29% and a negative return on equity of 57.51%. During the same period last year, the business posted ($2.64) EPS. On average, analysts expect Arcadia Biosciences to post $-2 EPS for the current fiscal year and $0 EPS for the next fiscal year.
Arcadia Biosciences Trading Down 0.7 %
RKDA opened at $4.05 on Friday. Arcadia Biosciences has a 12 month low of $1.85 and a 12 month high of $5.34. The stock has a fifty day moving average price of $3.24 and a 200-day moving average price of $2.96. The firm has a market cap of $5.52 million, a price-to-earnings ratio of -0.81 and a beta of 1.27.
Analyst Ratings Changes
View Our Latest Analysis on RKDA
About Arcadia Biosciences
Arcadia Biosciences, Inc produces and markets plant-based food and beverage products in the United States. The company develops crop improvements primarily in wheat to enhance farm economics by improving the performance of crops in the field, as well as their value as food ingredients. Its food, beverage, and body case products include GoodWheat, Zola coconut water, ProVault topical pain relief, and SoulSpring.
Further Reading
- Five stocks we like better than Arcadia Biosciences
- What is the FTSE 100 index?
- Airbnb Stock Attracts Attention With Strong Cash Flow Strategy
- CD Calculator: Certificate of Deposit Calculator
- MarketBeat Week in Review – 11/4 – 11/8
- REIT Stocks – Best REIT Stocks to Add to Your Portfolio Today
- Trump’s Return: Which Sectors Will Benefit Most?
Receive News & Ratings for Arcadia Biosciences Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Arcadia Biosciences and related companies with MarketBeat.com's FREE daily email newsletter.